Stoke Therapeutics, Inc.STOKNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+42.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+42.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 152.49% |
| 2024 | -7.13% |
| 2023 | -154.40% |
| 2022 | 52.37% |
| 2021 | -58.47% |
| 2020 | -35.96% |
| 2019 | -183.25% |
| 2018 | -103.64% |
| 2017 | 0.00% |